| dc.contributor.author | Jiménez Candil, Francisco Javier | |
| dc.contributor.author | Hernández, Jesús | |
| dc.contributor.author | Martín, Ana | |
| dc.contributor.author | Moriñigo Muñoz, José Luis | |
| dc.contributor.author | López, Rosana | |
| dc.contributor.author | Ledesma, Claudio | |
| dc.contributor.author | Martín Luengo, Cándido | |
| dc.date.accessioned | 2024-12-16T09:54:40Z | |
| dc.date.available | 2024-12-16T09:54:40Z | |
| dc.date.issued | 2013-02 | |
| dc.identifier.citation | Jiménez-Candil, J., Hernández, J., Martín, A., Moríñigo, J., López, R., Ledesma, C., & Martín-Luengo, C. (2013). Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients. Heart Rhythm, 10(2), 207-213. https://doi.org/10.1016/J.HRTHM.2012.10.028 | es_ES |
| dc.identifier.issn | 1547-5271 | |
| dc.identifier.uri | http://hdl.handle.net/10366/161177 | |
| dc.description.abstract | [EN]Antitachycardia pacing (ATP) fails to terminate 5% to 25% of ventricular tachycardias (VTs) occurring in implantable cardioverter-defibrillator patients. We speculated that small fluctuations in VT cycle length (CL) may be related to the efficacy of subsequent ATP. The purpose of this study was to determine the relationship between the R-R variations of the last 12 R-R intervals before ATP and the efficacy of the first ATP attempt. We studied 551 VTs (CL 329±35 ms) occurring in 67 patients. We also analyzed the percentage of variation (P-RR), which was calculated by dividing the mean difference between each R-R interval and the next one by the CL (×100), and the acceleration index (AI), which was calculated by dividing the CL of the first 6 R-R intervals by the CL of the next 6. The effectiveness of the first ATP therapy was 81%, being higher in VTs with AI<1 (85% vs 64%; P<.001). After classifying the events according to the tertiles of P-RR, ATP efficiency was better in higher values of P-RR (VTs with AI<1): 99% (third tertile) vs 85% (second tertile) vs 76% (first tertile), P<.001; and for VTs with AI≥1: 94% vs 68% vs 42% (P<.001). By logistic regression, P-RR (%; odds ratio 2.37; P<.001), and AI<1 (odds ratio 4.17; P<.001) were found to be independent predictors of successful first ATP attempts. Small changes in CL increase the effectiveness of ATP significantly. VTs with lower degrees of R-R fluctuations, especially when the pattern is a progressive CL shortening, are infrequently terminated by ATP. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Antitachycardiapacing | es_ES |
| dc.subject | Implantablecardioverter- defibrillator | es_ES |
| dc.subject | Ventriculartachycardia | es_ES |
| dc.subject.mesh | Aged | * |
| dc.subject.mesh | Adult | * |
| dc.subject.mesh | Risk Assessment | * |
| dc.subject.mesh | Follow-Up Studies | * |
| dc.subject.mesh | Humans | * |
| dc.subject.mesh | Defibrillators | * |
| dc.subject.mesh | Electrocardiography | * |
| dc.subject.mesh | Combined Modality Therapy | * |
| dc.subject.mesh | Middle Aged | * |
| dc.subject.mesh | Multivariate Analysis | * |
| dc.subject.mesh | Severity of Illness Index | * |
| dc.subject.mesh | Treatment Outcome | * |
| dc.subject.mesh | Cohort Studies | * |
| dc.subject.mesh | Survival Rate | * |
| dc.subject.mesh | Tachycardia | * |
| dc.subject.mesh | Logistic Models | * |
| dc.subject.mesh | Retrospective Studies | * |
| dc.title | Influence of cycle length variations on antitachycardia pacing effectiveness among ICD patients | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1016/j.hrthm.2012.10.028 | |
| dc.identifier.doi | 10.1016/j.hrthm.2012.10.028 | |
| dc.rights.accessRights | info:eu-repo/semantics/embargoedAccess | es_ES |
| dc.identifier.pmid | 23085131 | |
| dc.identifier.essn | 1556-3871 | |
| dc.journal.title | Heart Rhythm | es_ES |
| dc.volume.number | 10 | es_ES |
| dc.issue.number | 2 | es_ES |
| dc.page.initial | 207 | es_ES |
| dc.page.final | 2013 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/draft | es_ES |
| dc.subject.decs | humanos | * |
| dc.subject.decs | índice de gravedad de la enfermedad | * |
| dc.subject.decs | anciano | * |
| dc.subject.decs | estudios de seguimiento | * |
| dc.subject.decs | modelos logísticos | * |
| dc.subject.decs | mediana edad | * |
| dc.subject.decs | análisis multifactorial | * |
| dc.subject.decs | estudios retrospectivos | * |
| dc.subject.decs | tratamiento combinado | * |
| dc.subject.decs | tasa de supervivencia | * |
| dc.subject.decs | adulto | * |
| dc.subject.decs | desfibriladores | * |
| dc.subject.decs | resultado del tratamiento | * |
| dc.subject.decs | evaluación de riesgos | * |
| dc.subject.decs | estudios de cohortes | * |
| dc.subject.decs | electrocardiografía | * |
| dc.subject.decs | taquicardia | * |
Parcourir
Tout GredosCommunautés & CollectionsPar date de publicationAuteursSujetsTitresCette collectionPar date de publicationAuteursSujetsTitres
Mon compte
Statistiques
ENLACES Y ACCESOS
Derechos de autorPolíticasGuías de autoarchivoFAQAdhesión USAL a la Declaración de BerlínProtocolo de depósito, modificación y retirada de documentos y datosSolicitud de depósito, modificación y retirada de documentos y datos








